CymaBay Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
CymaBay Therapeutics, Inc.
CIK #0001042074
EDGAR Form CIK 2011 - 2025
10-K [0001042074]
10-Q [0001042074]
3 [0001042074]
4 [0001042074]
8-K [0001042074]
D [0001042074]
SC 13D [0001042074]
SC 13G [0001042074]
Form 13D/13G Filer Form 13D/13G Subject Filed
Janus Henderson Group PLC CymaBay Therapeutics Inc [2024-02-14]
Vanguard Group Inc CymaBay Therapeutics Inc [2024-02-13]
BlackRock Inc CymaBay Therapeutics Inc [2024-01-25]
RA Capital Management LP CymaBay Therapeutics Inc [2023-09-22]
Adage Capital Partners GP LLC CymaBay Therapeutics Inc [2023-09-11]
Perceptive Advisors LLC CymaBay Therapeutics Inc [2023-03-10]
BlackRock Inc CymaBay Therapeutics Inc [2022-07-08]
TCG Crossover Management LLC CymaBay Therapeutics Inc [2021-11-29]
Commodore Capital LP CymaBay Therapeutics Inc [2021-07-12]
Boxer Capital LLC CymaBay Therapeutics Inc [2020-09-24]
View All
Form 3/4/5 Subject 2011 - 2025
CymaBay Therapeutics, Inc.
Wiggans Thomas G
Emster Kurt von
Loewy Caroline M
McWherter Charles
Lefebvre Eric
Dorling Janet
Shantharam Harish
Dickinson Klara
Quinlan Paul T
Wills Robert James
Shah Sujal
Menold Daniel
Aghazadeh Behzad
Avoro Capital Advisors LLC
Kim Dennis D
Stuart Lewis J
Truex Paul F
von Emster Kurt
Goldfischer Carl
Booth Robert F.
Boudes Pol F
Weiland Robert J.
Stein Evan A
Martin Robert L.
OMara Patrick J.
Rosemark Kirk
Van Wart Harold
Lange Louis G
Kumar Hari
Penhoet Edward
Versant Side Fund II, LP
Versant Venture Capital II, LP
Versant Affiliates Fund II-A, LP
Alta Biopharma Partners III LP
Alta Biopharma Partners III GmbH & Co Beteiligungs KG
Alta Embarcadero Biopharma Partners III LLC
Terms | Privacy | Guide
tony@aum13f.com